China Pharma Holdings (CPHI) Receivables - Other: 2009-2025
Historic Receivables - Other for China Pharma Holdings (CPHI) over the last 12 years, with Sep 2025 value amounting to $61,275.
- China Pharma Holdings' Receivables - Other rose 31.62% to $61,275 in Q3 2025 from the same period last year, while for Sep 2025 it was $61,275, marking a year-over-year increase of 31.62%. This contributed to the annual value of $30,286 for FY2024, which is 80.82% down from last year.
- As of Q3 2025, China Pharma Holdings' Receivables - Other stood at $61,275, which was up 26.70% from $48,361 recorded in Q2 2025.
- China Pharma Holdings' 5-year Receivables - Other high stood at $1.7 million for Q3 2021, and its period low was $28,660 during Q2 2024.
- Its 3-year average for Receivables - Other is $52,586, with a median of $39,046 in 2025.
- Its Receivables - Other has fluctuated over the past 5 years, first tumbled by 97.96% in 2022, then skyrocketed by 442.04% in 2023.
- China Pharma Holdings' Receivables - Other (Quarterly) stood at $1.4 million in 2021, then crashed by 97.96% to $29,139 in 2022, then spiked by 442.04% to $157,944 in 2023, then plummeted by 80.82% to $30,286 in 2024, then skyrocketed by 31.62% to $61,275 in 2025.
- Its Receivables - Other stands at $61,275 for Q3 2025, versus $48,361 for Q2 2025 and $39,046 for Q1 2025.